Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9316
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 222 $6,921,282 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $6,921,282 Current and potential, with all options
- Last date to order 86% complete
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.
This IDC is part of the DLA's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which aims to establish multiple Prime Vendor Contracts to provide worldwide pharmaceutical support to the Defense Health Agency, Department of Defense, United States Coast Guard, and other government agencies. The unrestricted, fully competitive solicitation is expected to be issued in March 2024 and will remain open for 45 days, with the intent to make multiple regional awards to ensure the Department of Defense's resiliency and access to vital pharmaceuticals during contingencies or natural disasters.
Task orders
Show 40 more
Latest 50 of 222 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D9316?
SPE2DR25D9316 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D9316 worth?
Orders under SPE2DR25D9316 have obligated $6,921,282.
How many orders have been placed under contract SPE2DR25D9316?
222 orders have been placed under SPE2DR25D9316, the latest on August 7, 2026.
Who can order from contract SPE2DR25D9316?
SPE2DR25D9316 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9316 competed?
The extent of competition for SPE2DR25D9316 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV